Galderma will share exciting phase III data on its novel, investigational, ready-to-use liquid botulinum toxin A, RelabotulinumtoxinA, further reinforcing its unprecedented efficacy and safety in tr......
Juniper's converged optical routing solutions deliver scalability and performance, revolutionizing space, power and cost efficiency for the service provider
